阿尔茨海默病中的阿波脂蛋白E功能障碍:对miRNA调节,质标记物和粉样蛋白病理学的研究
Printha Wijesinghe1, Hao Ran Li1, Zhengyuan Ai1
1Department of Ophthalmology and Visual Sciences, Faculty of Medicine, Eye Care Centre, The University of British Columbia, Vancouver, BC, Canada.
Frontiers in aging neuroscience
|January 2, 2025
概括
小鼠的阿波利波蛋白E (ApoE) 功能障碍会影响大脑和眼睛的微RNA和蛋白质,导致阿尔茨海默氏症 (AD) 病理. 眼液可能为ApoE相关的神经退行变化提供新的生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 生物化学 生物化学
背景情况:
- 脂蛋白E (ApoE) 对于中枢神经系统 (CNS) 中的脂质稳定至关重要.
- APOE4等位基因是阿尔茨海默病 (AD) 的主要遗传风险因素.
- 在小鼠模型中的ApoE功能障碍反映了AD相关的脂质代谢,认知和神经退行症的缺陷.
研究的目的:
- 调查ApoE在阿尔茨海默氏病 (AD) 发病过程中的作用.
- 分析ApoE-knockout (ApoE-ko) 小鼠的大脑和眼睛样本,以确定ApoE功能障碍的潜在视网膜生物标志物.
- 检查饮食对ApoE-ko小鼠miRNA和mRNA表达的影响.
主要方法:
- 雌性ApoE-ko小鼠和常规和高脂肪饮食的野生类型对照的比较.
- 对微RNA (miRNA),信使RNA (mRNA) 和蛋白质标记物的分析 (Gfap, Iba1, Trem2, APP, Aβ).
- 检查大脑区域,眼睛组织和眼液.
主要成果:
- ApoE缺乏改变了大脑,眼组织和眼液中的miRNA和mRNA水平,其影响因年龄和饮食而改变.
- 在大脑和视网膜中观察到高质纤维酸性蛋白 (Gfap) 和粉样蛋白前体蛋白 (APP) /粉样β (Aβ) 积累.
- 在老年ApoE-ko小鼠中,特定的miRNAs (miR-146a和miR-15a) 被上调调,这表明它们可能是水生物标志物.
结论:
- 在中枢神经系统中,ApoE在调节炎症和粉原/血管原路径方面发挥着至关重要的作用.
- ApoE功能障碍会影响质平衡和APP/Aβ的清除.
- 液miRNAs,特别是miR-146a和miR-15a,显示为ApoE功能障碍和AD相关变化的非侵入性生物标志物具有前途.
相关概念视频
Alzheimer's Disease: Overview
311
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
311
Alzheimer's Disease: Treatment
125
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
125
Amyloid Fibrils
9.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.0K


